Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025

創傷壊死組織切除術の世界市場予測:製品別(酵素、自己溶解(ゲル、軟膏)、メカニカル(医療用ガーゼ)、外科、超音波)、創傷タイプ別(糖尿病性足潰瘍、静脈性脚、褥瘡、火傷)、エンドユーザー別(病院、クリニック)

◆タイトル:Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025
◆商品コード:MD 6326
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:132
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

arketsandMarkets社は創傷壊死組織切除術の世界市場が2020年8億2200万ドルから2025年11億6200万ドルまで、年平均7.2%成長すると予測しています。本調査レポートでは、創傷壊死組織切除術の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(酵素デブリードマン製品、自動分解製品、機械的デブリードマン製品、手術デブリードメント製品、超音波デブリードマン製品、その他デブリードメント製品)、創傷別(糖尿病性足潰瘍、圧力潰瘍、静脈性潰瘍、外科&外傷性創傷、やけど、その他)、エンドユーザー別(病院、クリニック、その他)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・創傷壊死組織切除術の世界市場:製品別(酵素デブリードマン製品、自動分解製品、機械的デブリードマン製品、手術デブリードメント製品、超音波デブリードマン製品、その他デブリードメント製品)
・創傷壊死組織切除術の世界市場:創傷別(糖尿病性足潰瘍、圧力潰瘍、静脈性潰瘍、外科&外傷性創傷、やけど、その他)
・創傷壊死組織切除術の世界市場:エンドユーザー別(病院、クリニック、その他)
・創傷壊死組織切除術の世界市場:地域別
・競争状況
・企業概要

“High prevalence of diabetes & associated wounds, increasing burn cases, and increasing awareness programs are driving the overall growth of the wound debridement market”
The wound debridement market is projected to reach a value of USD 1,162 million by 2025 from USD 822 million in 2020, at a CAGR of 7.2% during the forecast period. The growth in this market is attributed to the increasing prevalence of diabetic and pressure ulcers, availability of reimbursement in developed economies, and increasing product approvals. However, the high cost of products is expected to hamper market growth to a certain extent in the coming years.

“Enzymatic debridement products accounted for the largest share of the wound debridement market in 2019.”
Based on product, the wound debridement market is categorized into enzymatic, autolytic, mechanical, surgical, ultrasonic, and others. The enzymatic debridement products segment is expected to command the largest share of the global wound debridement market in 2020. This is primarily attributed to factors such as their high efficacy in debriding and strong market penetration.

“Diabetic foot ulcers register the highest growth in the wound debridement market during the forecast period.”
Based on wound type, the market has been segmented into diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, surgical & traumatic wounds, burns, and other wounds. The DFUs segment is expected to offer growth opportunities for market players during the forecast period, primarily due to the growing patient pool for the condition.

“North America will continue to dominate the wound debridement market during the forecast period.”
The wound debridement market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is the largest market for wound debridement, followed by Europe. Growth in the North American market can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. However, the Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.

Primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 32%, Tier 2 – 44%, and Tier 3 – 24%
• By Designation: C-level – 30%, D-level – 34%, and Others – 36%
• By Region: North America – 50%, Europe – 32%, Asia Pacific – 10%, and the Rest of the World – 8%


List of Companies Profiled in the Report
• Smith & Nephew (UK)
• B. Braun Melsungen AG (Germany)
• Coloplast (Denmark)
• ConvaTec (UK)
• Mölnlycke Healthcare (Sweden)
• Lohmann & Rauscher (Germany)
• Integra Lifesciences (US)
• Zimmer Biomet (US)
• Misonix (US)
• MediWound (Israel)
• Medline Industries (US)
• Welcare Industries S.P.A (Italy)
• Medaxis AG (Switzerland),
• PulseCare Medical, LLC (US)
• Arobella Medical, LLC (US)
• Advancis Medical (UK)
• RLS Global (Sweden)
• DeRoyal Industries (US)
• EZ Debride (US)
• PulseCare Medical (US)
• Söring GmbH (Germany)
• Suzhou and Science & Technology Development Corp (China).
Research Coverage:
This report provides a detailed picture of the global wound debridement market. It aims at estimating the size and future growth potential of the market across different segments. The report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound debridement market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to position their business better and make suitable go-to-market strategies. This will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, trends, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 16)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 19)
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 25)

4 PREMIUM INSIGHTS (Page No. – 28)
4.1 WOUND DEBRIDEMENT MARKET OVERVIEW
4.2 ASIA PACIFIC WOUND DEBRIDEMENT MARKET, BY PRODUCT & COUNTRY
4.3 WOUND DEBRIDEMENT MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. – 31)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing incidence of diabetes and associated wounds
5.2.1.2 Rising incidence of burn injuries
5.2.1.3 Awareness programs for wound care and management
5.2.2 OPPORTUNITIES
5.2.2.1 Growth potential of emerging economies
5.2.3 CHALLENGES
5.2.3.1 High cost of enzymatic debridement and surgical devices
5.2.4 TRENDS
5.2.4.1 Focus on autolytic debridement & disposable products

6 WOUND DEBRIDEMENT MARKET, BY PRODUCT (Page No. – 35)
6.1 INTRODUCTION
6.2 ENZYMATIC DEBRIDEMENT PRODUCTS
6.2.1 ENZYMATIC DEBRIDEMENT PRODUCTS DOMINATE THE WOUND DEBRIDEMENT MARKET
6.3 AUTOLYTIC DEBRIDEMENT PRODUCTS
6.3.1 GELS
6.3.1.1 Gels hold the largest share of the autolytic debridement products market
6.3.2 OINTMENTS
6.3.2.1 North America shows the highest demand for ointments
6.4 MECHANICAL DEBRIDEMENT PRODUCTS
6.4.1 MEDICAL GAUZES
6.4.1.1 North America dominates the medical gauzes market
6.4.2 MECHANICAL DEBRIDEMENT PADS
6.4.2.1 APAC to show the highest growth in the mechanical debridement pads market
6.5 SURGICAL DEBRIDEMENT PRODUCTS
6.5.1 BETTER CLINICAL OUTCOMES ASSOCIATED WITH SURGICAL DEBRIDEMENT PRODUCTS TO SUPPORT THE MARKET GROWTH
6.6 ULTRASONIC DEBRIDEMENT PRODUCTS
6.6.1 ULTRASONIC DEBRIDEMENT PRODUCTS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
6.7 OTHER DEBRIDEMENT PRODUCTS

7 WOUND DEBRIDEMENT MARKET, BY WOUND TYPE (Page No. – 44)
7.1 INTRODUCTION
7.2 DIABETIC FOOT ULCERS
7.2.1 INCREASING EMPHASIS ON AGGRESSIVE MANAGEMENT OF DIABETIC FOOT ULCERS HAS SUPPORTED MARKET GROWTH
7.3 PRESSURE ULCERS
7.3.1 INCREASING GERIATRIC POPULATION HAS RAISED ULCER PREVALENCE RATE
7.4 VENOUS LEG ULCERS
7.4.1 INCREASING PREVALENCE OF RISK FACTORS DRIVES DEMAND FOR VLU WOUND DEBRIDEMENT PRODUCTS
7.5 SURGICAL & TRAUMATIC WOUNDS
7.5.1 RISING NUMBER OF WOUNDS, CUTS, AND TRAUMA CASES WILL DRIVE MARKET GROWTH
7.6 BURNS
7.6.1 HIGH INCIDENCE OF BURNS DRIVES DEMAND FOR WOUND DEBRIDEMENT PRODUCTS
7.7 OTHER WOUNDS

8 WOUND DEBRIDEMENT MARKET, BY END USER (Page No. – 51)
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HOSPITALS DOMINATE THE WOUND DEBRIDEMENT MARKET, BY END USER
8.3 CLINICS
8.3.1 CLINICS ARE THE FIRST POINT OF CONTACT FOR PATIENTS AND SHOW HIGH DEMAND FOR DEBRIDEMENT PRODUCTS
8.4 OTHER END USERS

9 WOUND DEBRIDEMENT MARKET, BY REGION (Page No. – 56)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 The US dominates the global wound debridement market
9.2.2 CANADA
9.2.2.1 Growth in the diabetic patient population will support product demand
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European market
9.3.2 FRANCE
9.3.2.1 Increasing diabetes and ulcer prevalence drive the market in France
9.3.3 UK
9.3.3.1 Rising geriatric population in the country to support market growth
9.3.4 ITALY
9.3.4.1 Italy is an emerging market for wound debridement
9.3.5 SPAIN
9.3.5.1 Increasing life expectancy and growing geriatric population will favor wound debridement product demand in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China dominates the Asia Pacific wound debridement market
9.4.2 INDIA
9.4.2.1 High number of burn cases to support market growth
9.4.3 JAPAN
9.4.3.1 Availability of reimbursement to support the growth of the market
9.4.4 AUSTRALIA
9.4.4.1 Awareness of diabetes management has risen, indicating favorable prospects for wound debridement
9.4.5 REST OF APAC
9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE (Page No. – 95)
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2019
10.2.1 WOUND DEBRIDEMENT MARKET FOR HOSPITALS
10.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
10.4 VENDOR DIVE
10.4.1 VISIONARY LEADERS
10.4.2 INNOVATORS
10.4.3 DYNAMIC DIFFERENTIATORS
10.4.4 EMERGING COMPANIES
10.5 COMPETITIVE SCENARIO
10.5.1 PRODUCT LAUNCHES & APPROVALS
10.5.2 AGREEMENTS AND COLLABORATIONS
10.5.3 EXPANSIONS

11 COMPANY PROFILES (Page No. – 101)
(Business overview, Products offered, Recent developments, SWOT analysis & MnM View)*
11.1 SMITH & NEPHEW
11.2 B. BRAUN MELSUNGEN AG
11.3 LOHMANN & RAUSCHER
11.4 MÖLNLYCKE HEALTH CARE AB
11.5 CONVATEC
11.6 COLOPLAST CORP
11.7 INTEGRA LIFESCIENCES
11.8 ZIMMER BIOMET
11.9 MISONIX
11.10 MEDLINE INDUSTRIES
11.11 WELCARE INDUSTRIES S.P.A
11.12 MEDAXIS
11.13 PULSECARE MEDICAL
11.14 AROBELLA MEDICAL
11.15 ADVANCIS MEDICAL
11.16 RLS GLOBAL
11.17 DEROYAL INDUSTRIES
11.18 EZ DEBRIDE
11.19 SÖRING
11.20 SUZHOU AND SCIENCE & TECHNOLOGY DEVELOPMENT
*Details on Business overview, Products offered, Recent developments, SWOT analysis & MnM View might not be captured in case of unlisted companies.



★調査レポート[創傷壊死組織切除術の世界市場予測:製品別(酵素、自己溶解(ゲル、軟膏)、メカニカル(医療用ガーゼ)、外科、超音波)、創傷タイプ別(糖尿病性足潰瘍、静脈性脚、褥瘡、火傷)、エンドユーザー別(病院、クリニック)] ( Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025 / MD 6326) 販売に関する免責事項
[創傷壊死組織切除術の世界市場予測:製品別(酵素、自己溶解(ゲル、軟膏)、メカニカル(医療用ガーゼ)、外科、超音波)、創傷タイプ別(糖尿病性足潰瘍、静脈性脚、褥瘡、火傷)、エンドユーザー別(病院、クリニック)] ( Wound Debridement Market by Product (Enzymatic, Autolytic (Gels, Ointments), Mechanical (Medical Gauzes), Surgical, Ultrasonic), Wound Type (Diabetic Foot Ulcers, Venous Leg, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2025 / MD 6326) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆